The forthcoming Word Health Organization (WHO) includes TFE3-rearranged renal cell carcinoma and TFEB-rearranged renal cell carcinoma as separate entities differentiating from the previous one in which the term “MiT family translocation renal cell carcinoma” encompassed both tumor types [1]. This evidence concerns the gene TFEB and neoplasm.